Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Clinician selected for leading female researcher development programme
Dr Abbe Crawford has been selected for the fourth round of the SUSTAIN training and development initiative.

RVC's Dr Abbe Crawford selected for fourth round of SUSTAIN

An RVC clinician has been selected for a leading female researcher development programme.

Neurology and neurosurgery clinician Dr Abbe Crawford has been selected for the fourth round of SUSTAIN, a training and development initiative, which supports female researchers in their first independent position within the scientific community.

Dr Crawfords research centres on brain abnormalities associated with Duchenne Muscular Dystrophy (DMD), the most common lethal genetic disorder diagnosed in childhood. Using various techniques to study brain function in the diseased state, her research aims to understand why DMD patients show abnormal brain function and to ultimately develop therapeutic strategies to overcome these brain deficits.

Being a member of SUSTAIN will allow Dr Crawford to join a network of early-career female researchers. The programme runs for one year and will include mentoring from Academy Fellows, peer-coaching and a series of bespoke training workshops.

“I feel very lucky to be joining the SUSTAIN programme. It is a wonderful opportunity to become part of a supportive cohort of like-minded female researchers and to receive training from leading experts in a range of key, yet often undertaught, areas including mentorship, negotiation, and digital resilience,” said Dr Crawford.

“This course comes at an ideal time as I try to develop an independent research programme through my work with colleagues at the Royal Veterinary College. I am confident that the skills, knowledge and support network I will gain from this course will build upon the RVC’s ongoing support and allow me to develop and thrive as I begin this exciting chapter of my career.”

Professor Jonathan Elliott, vice-principal for research and innovation at the RVC, added: “We are incredibly excited about Abbe’s selection in this programme and take great pride in watching her research and career go from strength-to-strength.

“The RVC is renowned for its research excellence and we are committed to supporting all of our colleagues as they pursue their own personal development. In particular, there is an urgent need to develop the research careers of veterinary clinical scientists who work at the interface between veterinary and human health in the way that Abbe is doing”.

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.